RecruitingUnknown phaseFemale onlyBreast cancerLung cancerCervical cancerColorectal cancerGastric cancerLiver cancerBladder cancerHead and neck cancerOther cancers
NCT06904365ClinicalTrials.gov ↗
Female patients with early onset (\<50 years old) pelvic malignancies such as uterine and rectal cancers are rising in incidence, which often requires pelvic radiation; many of these patients are premenopausal and at a high risk of premature ovarian failure from radiotherapy. Premature ovarian failure carries significant cardiac, musculoskeletal, sexual, and psychosocial morbidity. Ovarian transposition carries variable success rates, is not readily accessible to the general population, and can still be at risk of clinically significant radiotherapy doses. There is an unmet need for innovative techniques to protect ovarian function.